The invention provides pharmaceutical compositions and methods of treating
immunological disorders. The invention also provides pharmaceutical
compositions and methods of inducing eosinophil apoptosis, and methods
for treating eosinophil-associated disorders comprising inducing
eosinophil apoptosis in an individual in need thereof.